New trial tests which drug combo works better for Tough-to-Treat lung cancer
Disease control
Recruiting now
This study compares two different immunotherapy and chemotherapy combinations for people with advanced lung cancer that lacks a specific biomarker (TTF-1 negative). Researchers want to see if a treatment without one particular drug (pemetrexed) works better than the standard trea…
Phase: PHASE4 • Sponsor: Nikolaj Frost MD • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC